CAS RN: 55478-78-9
5-BroMo[1,2,4]triazolo[1,5-a]pyrazine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260113
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 55478-78-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Hong Kong
Inquiry
55478-78-9 / 5-bromo-[1,2,4]triazolo[1,5-a]pyrazine
Standard CAS: 55478-78-9
Multi CAS: No
Basic Information
copy
CAS
55478-78-9 copy
Multi CAS
No copy
Molecular Formula
BC5H3Rn4 copy
Molecular Weight
199.010000 copy
Exact Mass
197.954110 copy
InChI
InChI=1S/C5H3BrN4/c6-4-1-7-2-5-8-3-9-10(4)5/h1-3H copy
InChIKey
ZGVWVYMGLBYAKU-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Aromatic heavy atom count
9 copy
H-bond acceptors
4 copy
Molar refractivity
38.48 copy
TPSA
43.08 copy
LogP / Solubility
WLOGP
0.89 copy
MLOGP
0.78 copy
XLogP3
0.7 copy
Consensus LogP
0.79 copy
Log S (ESOL)
-2.3 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.83 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.69 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.3 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy